Hematology-American Society of Hematology Education Program

Papers
(The H4-Index of Hematology-American Society of Hematology Education Program is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Diagnosis and therapeutic decision-making for the neutropenic patient61
When should gene therapy be considered for transfusion-dependent β-thalassemia patients?58
Your chemo is no good here: management of high-risk MCL54
Inherited thrombophilia and recurrent miscarriage: is there a role for anticoagulation during pregnancy?36
Neurological manifestations of MGUS35
Anticoagulation at the end of life: whether, when, and how to treat33
On the horizon: upcoming new agents for the management of ITP33
Labor and delivery: DIC, HELLP, preeclampsia30
Mastocytosis demystified29
Inpatient recognition and management of HLH26
Hematopoietic cell transplantation for sickle cell disease: updates and future directions26
Recognizing, defining, and managing CAR-T hematologic toxicities26
Has PD-1 blockade changed the standard of care for cHL?25
Bispecific antibody therapies25
Mutation- and MRD-informed treatment decisions for the transplant-eligible AML patient24
Individualized patient care in nodular lymphocyte-predominant Hodgkin lymphoma24
T-cell–based therapies for treating relapsed or refractory mantle cell lymphoma23
To consolidate or not to consolidate: the role of autologous stem cell transplantation in MCL22
Logistics, risks, and benefits of automated red blood cell exchange for patients with sickle cell disease22
Double-refractory Hodgkin lymphoma: tackling relapse after brentuximab vedotin and checkpoint inhibitors22
Selecting initial therapy in CLL21
Divergent paths: management of early relapsed follicular lymphoma21
0.043944120407104